Zydus Philippines Launched In New Generic Drive That Worries Some
This article was originally published in PharmAsia News
Philippines government officials hailed the launching of a subsidiary of Indian drug maker Zydus Cadila as bringing much-needed generic competition to the Philippines. But the head of the Drugstores Association of the Philippines said he was worried the presence of Zydus Philippines and other drug importers would lead to a saturation of the drugs' market, causing harm to the local pharmaceutical industry. She warned that local companies might find it difficult to compete with MNCs attracted by the country's new law encouraging cheaper drugs. (Click here for more
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.